Showing results (261-270 of 439) with videos related to

Sort By:
Pageof 44
Metabolism Open|August 20, 2020
Beneficial effects of running and milk protein supplements on Sirtuins and risk factors of metabolic disorders in rats with low aerobic capacityS Lensu, S P Pekkala, A Mäkinen, et al.
Metabolism Open|August 20, 2020
Intra-individual reproducibility of galectin-1, haptoglobin, and nesfatin-1 as promising new biomarkers of immunometabolismMatthew Schenk, Robin Reichmann, Liselot Koelman, et al.
Metabolism Open|August 20, 2020
Hyperoxia affects the lung tissue: A porcine histopathological and metabolite study using five hours of apneic oxygenationSigríður Olga Magnúsdóttir, Raluca Georgiana Maltesen, Lise Haugaard Banch, et al.
Metabolism Open|August 20, 2020
A cost-effective, analytical method for measuring metabolic load of mitochondriaJames F E Grey, Amelia R Townley, Nicola M Everitt, et al.
Metabolism Open|August 20, 2020
Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA studyAkiko Morimoto, Manabu Kadoya, Miki Kakutani-Hatayama, et al.
Metabolism Open|August 20, 2020
Impact of a FTO gene risk variant on variables of energy metabolism in adults with obesity class 2 and 3Ann Kristin H de Soysa, Marie Klevjer, Valdemar Grill, et al.
Metabolism Open|May 1, 2023
Aldehyde dehydrogenase 2 polymorphism is an important gene for insulin resistance in Japanese patients with type 2 diabetesTsuyoshi Okura, Risa Nakamura, Mari Anno, et al.
Metabolism Open|April 23, 2021
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up studyDong Ji, Guo-Feng Chen, Xiao-Xia Niu, et al.
Metabolism Open|March 16, 2023
New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: A systematic review and meta-analysisViolet Dismas Kajogoo, Wondwossen Amogne, Girmay Medhin
Metabolism Open|March 16, 2023
Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysisAkira Mima, Hidemasa Gotoda, Rina Lee, et al.
Pageof 44